Protagonist Therapeutics IncPTGX
Price$139.19

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Mar 2026
Market Price $139.19Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 11.8%
Volatility vs market (adjusted beta)1.53

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetProtagonist Therapeutics IncPTGXHealth Care
Valuation
P/E135.1×
P/S125.6×
P/B12.2×
EV / Revenue119.9×
EV / EBITDA—
Profitability
Gross margin—
Operating margin78.8%
Net margin111.9%
FCF margin176.3%
Returns
ROE9.9%
ROA9.4%
ROIC—
Growth
Revenue growth (YoY)-83.0%
5-yr fwd EPS growth—
Financial strength
Debt / Equity—
Current ratio21.71×
Altman Z-Score128.9
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.